Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks

Financière de Tubize

Market Cap: €9.2b

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.

UCB

Market Cap: €45.6b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

argenx

Market Cap: €47.0b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.